These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12105131)
1. Amiloride, a specific drug for hypertension in black people with T594M variant? Baker EH; Duggal A; Dong Y; Ireson NJ; Wood M; Markandu ND; MacGregor GA Hypertension; 2002 Jul; 40(1):13-7. PubMed ID: 12105131 [TBL] [Abstract][Full Text] [Related]
2. Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride. Hollier JM; Martin DF; Bell DM; Li JL; Chirachanchai MG; Menon DV; Leonard D; Wu X; Cooper RS; McKenzie C; Victor RG; Auchus RJ Hypertension; 2006 Mar; 47(3):428-33. PubMed ID: 16432044 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin. Swift PA; Macgregor GA Adv Ren Replace Ther; 2004 Jan; 11(1):76-86. PubMed ID: 14730541 [TBL] [Abstract][Full Text] [Related]
4. Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Baker EH; Dong YB; Sagnella GA; Rothwell M; Onipinla AK; Markandu ND; Cappuccio FP; Cook DG; Persu A; Corvol P; Jeunemaitre X; Carter ND; MacGregor GA Lancet; 1998 May; 351(9113):1388-92. PubMed ID: 9593408 [TBL] [Abstract][Full Text] [Related]
5. T594M variant of the epithelial sodium channel beta-subunit gene and hypertension in individuals of African ancestry in South Africa. Nkeh B; Samani NJ; Badenhorst D; Libhaber E; Sareli P; Norton GR; Woodiwiss AJ Am J Hypertens; 2003 Oct; 16(10):847-52. PubMed ID: 14553964 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome. Jeunemaitre X; Bassilana F; Persu A; Dumont C; Champigny G; Lazdunski M; Corvol P; Barbry P J Hypertens; 1997 Oct; 15(10):1091-100. PubMed ID: 9350583 [TBL] [Abstract][Full Text] [Related]
7. The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride. Swift PA; MacGregor GA Am J Pharmacogenomics; 2004; 4(3):161-8. PubMed ID: 15174897 [TBL] [Abstract][Full Text] [Related]
8. T594M and G442V polymorphisms of the sodium channel beta subunit and hypertension in a black population. Dong YB; Zhu HD; Baker EH; Sagnella GA; MacGregor GA; Carter ND; Wicks PD; Cook DG; Cappuccio FP J Hum Hypertens; 2001 Jun; 15(6):425-30. PubMed ID: 11439319 [TBL] [Abstract][Full Text] [Related]
9. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Pratt JH; Ambrosius WT; Agarwal R; Eckert GJ; Newman S Hypertension; 2002 Dec; 40(6):903-8. PubMed ID: 12468577 [TBL] [Abstract][Full Text] [Related]
10. Epithelial sodium channel blockade and new β-ENaC polymorphisms among normotensive and hypertensive adult Nigerians. Elias SO; Sofola OA; Jaja SI Clin Exp Hypertens; 2019; 41(2):144-151. PubMed ID: 29580127 [TBL] [Abstract][Full Text] [Related]
11. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Saha C; Eckert GJ; Ambrosius WT; Chun TY; Wagner MA; Zhao Q; Pratt JH Hypertension; 2005 Sep; 46(3):481-7. PubMed ID: 16116042 [TBL] [Abstract][Full Text] [Related]
13. T594M mutation of the epithelial sodium channel beta-subunit gene in pre-eclampsia and eclampsia in Black South African women. Pegoraro RJ; Roberts CB; Rom L; Moodley J BJOG; 2004 Sep; 111(9):1012-3. PubMed ID: 15327619 [TBL] [Abstract][Full Text] [Related]
14. The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure. Sagnella GA; Swift PA Curr Pharm Des; 2006; 12(18):2221-34. PubMed ID: 16787251 [TBL] [Abstract][Full Text] [Related]
15. Japanese individuals do not harbor the T594M mutation but do have the P592S mutation in the C-terminus of the beta-subunit of the epithelial sodium channel: the Ohasama study. Matsubara M; Ohkubo T; Michimata M; Hozawa A; Ishikawa K; Katsuya T; Nagai K; Tsuji I; Higaki J; Araki T; Satoh H; Hisamichi S; Ito S; Ogihara T; Imai Y J Hypertens; 2000 Jul; 18(7):861-6. PubMed ID: 10930183 [TBL] [Abstract][Full Text] [Related]
16. The association of the R563Q genotype of the ENaC with phenotypic variation in Southern Africa. Jones ES; Owen EP; Rayner BL Am J Hypertens; 2012 Dec; 25(12):1286-91. PubMed ID: 22895453 [TBL] [Abstract][Full Text] [Related]
17. Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Warnock DG; Bell PD Hypertension; 2005 Sep; 46(3):469-70. PubMed ID: 16116049 [No Abstract] [Full Text] [Related]
18. Six missense mutations of the epithelial sodium channel beta and gamma subunits in Japanese hypertensives. Kamide K; Tanaka C; Takiuchi S; Miwa Y; Yoshii M; Horio T; Kawano Y; Miyata T Hypertens Res; 2004 May; 27(5):333-8. PubMed ID: 15198480 [TBL] [Abstract][Full Text] [Related]
19. A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans. Su YR; Rutkowski MP; Klanke CA; Wu X; Cui Y; Pun RY; Carter V; Reif M; Menon AG J Am Soc Nephrol; 1996 Dec; 7(12):2543-9. PubMed ID: 8989732 [TBL] [Abstract][Full Text] [Related]
20. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]